|Other names||NSC-33170; Chloroacetoxyprogesterone; CAP; 6α-Chloro-17α-acetoxyprogesterone; 6α-Chloro-17α-acetoxypregn-4-ene-3,20-dione|
|Drug class||Progestogen; Progestogen ester|
|Chemical and physical data|
|Molar mass||406.95 g·mol−1|
|3D model (JSmol)|
Hydromadinone acetate (developmental code name NSC-33170), also known as chloroacetoxyprogesterone (CAP), as well as 6α-chloro-17α-acetoxyprogesterone or 6α-chloro-17α-acetoxypregn-4-ene-3,20-dione, is a steroidal progestin of the 17α-hydroxyprogesterone group that was never marketed. It is the C17α acetate ester of hydromadinone, which, similarly, was never marketed.
|This article about a steroid is a stub. You can help Wikipedia by expanding it.|
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|